New data boosts Novo against Sanofi in insulin-market fight

Carly Helfand Novo Nordisk has some new data in hand that could help a safety advantage make its way onto the label of new drug Tresiba–and win it points against heavyweight ...

Merck may appeal to Supreme Court after again losing fight to protect Cubicin patents

Eric Palmer Merck & Co. is running low on options after a federal appeals court Thursday again declined to back four patents that would have held at bay for 5 more years generics ...

More grist for PCSK9 fight as Amgen sets up EU to pay about half as much as U.S.

Tracy Staton Last week, Amgen won its much-anticipated FDA approval for the PCSK9 cholesterol-fighter Repatha and promptly set a price of $ 14,100 per year. But even after pharmacy ...

Cancer docs try to rally public behind plan to fight drug prices

Eric Palmer Cancer doctors at the famed Mayo Clinic have been up in arms about escalating prices of cancer drugs. Now they have recruited a bunch of colleagues and are trying to rile ...

Ariad activists rabble for Berger’s job and mount a proxy fight

Damian Garde Activist investor Alex Denner has made the rumors official: He wants Ariad Pharmaceuticals CEO Harvey Berger out, and he's willing to mount a proxy fight to get his ...

Ariad activists strike up proxy fight to replace CEO Berger

Carly Helfand Let the proxy fight begin. Activist hedge fund and major Ariad Pharmaceuticals shareholder Sarissa Capital has its own ideas for who it wants in the company's CEO ...

Activists ready to fight for Ariad CEO’s ouster: CNBC

Carly Helfand Industry-watchers knew a shake-up could be in Ariad Pharmaceuticals' future when Alex Denner, founder of activist hedge fund Sarissa Capital and protégé ...

Allergan loses fight to block Ackman from voting for a Valeant takeover

Carly Helfand Valeant and partner Bill Ackman have dodged a serious roadblock in their quest to acquire Allergan. A 9.7% roadblock, if you will. FiercePharma News

Pfizer, Ranbaxy prevail in antitrust fight over Lipitor generics

Tracy Staton Pfizer and Ranbaxy Laboratories persuaded a U.S. judge to toss out an antitrust lawsuit accusing them of conspiring to delay generic versions of the cholesterol-fighting ...

AstraZeneca unit rolls out preemie newspaper ads to fight Synagis limits

Tracy Staton Drugmakers cheer when doctors' groups revise treatment guidelines to include new drugs. What happens when these powerful professional associations change those recommendations ...

Defensive Allergan plots 1,500 job cuts, hikes forecast to fight off Valeant

Carly Helfand Allergan's pulled back the veil on the restructuring it's hoping will lure shareholders away from Valeant's $ 53 billion hostile buyout bid. Among the blueprints: ...

France health minister says EU will fight price of Gilead’s Sovaldi

Eric Palmer Resistance to the price that Gilead Sciences has put on Sovaldi, a drug that will cure millions of hepatitis C, is reaching a fever pitch. Now 14 European countries are ...
© 2019 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS